• Users Online: 261
  • Print this page
  • Email this page
Year : 2019  |  Volume : 21  |  Issue : 3  |  Page : 167-174

The efficacy of positron emission tomography-CT in simultaneously detected nodules in patients with lung cancer

1 Department of Chest Diseases, Kartal Dr. Lütfi Kirdar Training and Research Hospital, Istanbul, Turkey
2 Department of Chest Diseases, Faculty of Medicine, Koç University, Istanbul, Turkey
3 Department of Chest Diseases, Faculty of Medicine, Yeditepe University, Istanbul, Turkey

Correspondence Address:
Dr. Coskun Dogan
Neslişah Street, Teknik Yapi Up City Apartment, B2 Block Flat nr: 40 Ugur Mumcu, Kartal, Istanbul
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ejop.ejop_77_18

Rights and Permissions

BACKGROUND: The aim of this study is to evaluate the efficacy of positron emission tomography-computed tomography (PET-CT) in the diagnosis of ≤1 cm nodules detected during lung cancer diagnosis. MATERIALS AND METHODS: Patients with pulmonary parenchymal nodules ≤1 cm during the diagnosis of lung cancer between January 2014 and December 2016 were included in the study. The radiologic (size, location, shape, and contour properties) and radiometabolic (presence of fluoro 2-deoxyglucose [FDG] uptake in the nodule, presence and number of PET-CT mediastinal lymphadenopathy [LAP] uptake, mediastinal LAP maximum standard uptake value [SUVmax], presence and number of PET-CT extrapulmonary metastasis) features of the nodules were recorded. Nodules that were followed for at least 6 months and unchanged in size were considered benign, and those that increased or decreased in size or completely regressed were considered malignant. RESULTS: Of a total of 167 patients with lung cancer, 116 (69.4%) had no nodules and 51 (30.5%) had nodules. Of the 51 patients with nodules, 27 (53%) had benign and 24 (47%) had malignant nodules. Compared with patients with benign nodules, the FDG uptake rate, SUVmax values, mediastinal LAP uptake in PET-CT, SUVmax value of the mediastinal LAP with uptake, the number of mediastinal LAPs with uptake, and reported the presence and number of extrapulmonary distant organ metastases in PET-CT were statistically significantly higher in malignant nodules (P < 0.05). Moreover, FDG uptake of the nodule in PET-CT and the presence of mediastinal LAP uptake in PET-CT were independent predictors of malignancy of the nodules (P < 0.05). CONCLUSION: PET-CT parameters other than SUVmax can be used to interpret accompanying nodules smaller than 1 cm in patients with lung cancer.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded169    
    Comments [Add]    

Recommend this journal